You just read:

Therapix Biosciences Filed an Application with the FDA to Approve an "Orphan" Designation for the Drug Developed Based on the Entourage Technology for Treating Tourette's Syndrome

News provided by

Therapix Biosciences

Jun 15, 2016, 08:00 ET